Kuros Biosciences AG (YTSN)

you sure its not HOMO (hope of missing out) like jeff foxworthy says ...I just had to lol

Trump’s Quantum Computing Orders Put RGTI, IONQ, QBTS and QUBT Back in the Spotlight

June 23, 2026

Quantum computing stocks are back in focus after President Donald Trump signed two executive orders aimed at speeding up U.S. quantum development and protecting government

Ern Heaven is still alive and still taking blarcamesine each and every day!!!

https://m.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,

😃.. yeah, I don't get out much..

Trump signs orders to accelerate quantum adoption, boost cyber defense

June 23, 2026

ETInfleqtion, Inc. (INFQ) Stock, IBM Stock, IONQ Stock, RGTI Stock, QBTS Stock, QUBT Stock, ARQQ Stock, GFS Stock, QTUM, PANW Stock, CRWD Stock, FTNT Stock, ZS Stock, OKTA Stock, NET St

$$$ Today is the Day $$$$

$$$SFRX$

Omdia: Global Smartphone Average Selling Price to Reach $565 in 2026 as Vendors Prioritize Value Over VolumeJune 23, 2026 5:18 AM
Business Wire Omdia’s latest research shows that the global smartphone market is undergoing a structural shift as rising component costs and geopoli

$IBM upgraded to Overweight from Neutral at $JPM - raises PT to $291 from $270

Great video..getting to be time to go to where that whale is..The ocean is vast, never know what you will encounter..Go IBAT! Lets see what the day brings..

Trump signs quantum computer executive order for futuristic machines

June 23, 2026

Donald Trump has signed an executive order to accelerate the development of quantum computers in an effort to supercharge scientific discoveries

The US president was joined

Let them push it back

You are too smart for us!

Please note that Infineon shares have gone up by 200% in the last few months!

https://www.belganewsagency.eu/hundreds-of-belgian-organisations-hit-by-cyber-attack
ACT NOW WITH WAVE.

AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus InfectionJune 23, 2026 5:00 AM
PR Newswire (US) MAVIRET® (glecaprevir/pibrentasvir) is now approved

Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C VirusJune 23, 2026 5:10 AM
Business Wire MAVIRET® (Glecaprevir/Pibrentasvir) is the Only Treatment Appr

https://unn.ua/en/news/five-eyes-intelligence-agencies-warn-of-ai-models-capable-of-destructive-cyberattacks-emerging-within-months
ACT RIGHT NOW WITH WAVE.

https://en.interfax.com.ua/news/general/1178788.html
ACT NOW WITH WAVE.

Momentum for ADTX is strongly bearish.

The 14-period Slow Stochastic oscillator is below 20, the level which many analysts call oversold. This means that investors have been actively selling shares and driving the price lower.

LSEG maintains a price target of $61

for ADTX.

On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.

Good morning CLNVers 

TKOI is correcting within a bullish trend.

Although its MACD is presently below the signal line, shares remain 98.2% above an upwards sloping 200-day moving average. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.